July 6, 2020

The Globe and Mail | Top Canadian biotech investor on the firms most likely to turn COVID-19 drug trials into treatments and when a vaccine may arrive

Our CEO, Brian Bloom, was featured in The Globe and Mail. He shares his thoughts with Tim Shufelt and describes the current biotech landscape, with a special focus on Canadian companies that are contributing to COVID-19 pandemic research and drug development.

Read the original article here.